Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications ; volume:21 ; number:1 ; day:17 ; month:5 ; year:2019 ; pages:1-14 ; date:12.2019
Breast cancer research ; 21, Heft 1 (17.5.2019), 1-14, 12.2019
- Creator
-
Jézéquel, Pascal
Kerdraon, Olivier
Hondermarck, Hubert
Guérin-Charbonnel, Catherine
Lasla, Hamza
Gouraud, Wilfried
Canon, Jean-Luc
Gombos, Andrea
Dalenc, Florence
Delaloge, Suzette
Lemonnier, Jérôme
Loussouarn, Delphine
Verrièle, Véronique
Campone, Mario
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-019-1148-6
- URN
-
urn:nbn:de:101:1-2019100903033370118371
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jézéquel, Pascal
- Kerdraon, Olivier
- Hondermarck, Hubert
- Guérin-Charbonnel, Catherine
- Lasla, Hamza
- Gouraud, Wilfried
- Canon, Jean-Luc
- Gombos, Andrea
- Dalenc, Florence
- Delaloge, Suzette
- Lemonnier, Jérôme
- Loussouarn, Delphine
- Verrièle, Véronique
- Campone, Mario
- SpringerLink (Online service)
Other Objects (12)
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Recent advances in therapeutic strategies for triple-negative breast cancer
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Recent advances in therapeutic strategies for triple-negative breast cancer
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Recent advances in therapeutic strategies for triple-negative breast cancer
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities